Are the Tradeoffs from Prior Authorization Worth It?
In his latest column, President and CEO Dr. Drew Altman asks if prior authorization review could be eliminated entirely, discussing how it might be done and the tradeoffs.
View the Latest: Access to Care
Filter
-
-
5 Key Facts About Medicaid Prescription Drugs
Issue BriefTo provide context for emerging debates about federal actions to address prescription drug costs, this issue brief highlights five key facts about Medicaid prescription drug coverage, payment, and administration.
-
Status of State Medicaid Expansion Decisions
InteractiveThis page displays an interactive map of the current status of state decisions on the Affordable Care Act's Medicaid expansion. Additional Medicaid expansion resources are listed (with links) below the map.
-
How Does Cost Affect Access to Health Care?
Issue BriefThis analysis explores trends in how the cost of healthcare affects access to care in the U.S. using National Health Interview Survey (NHIS) data. In 2024, about 1 in 6 adults (17%) reported delaying or not getting healthcare due to cost
-
Oral Contraceptive Pills: Access and Availability
Issue BriefThis brief provides an overview of oral contraception, discusses private insurance and Medicaid coverage, and reviews strategies to promote and expand women’s access to oral contraceptives.
-
What Medicare’s Temporary Program Covering GLP-1s for Obesity Means for Beneficiaries
Quick TakeCMS’s efforts to expand Medicare coverage of GLP-1s for obesity could provide substantial benefits to millions of Medicare beneficiaries, given the potential demand for these highly effective medications…There are potential drawbacks to the short-term program, however.
-
Litigation Involving Reproductive Health and Rights in the Federal Courts
FeatureThis State and Federal Reproductive Rights Litigation tracker aggregates information about ongoing litigation regarding abortion bans and restrictions, FDA approval of Mifepristone (an abortion pill) and other federal regulations.
-
Health and Health Care Experiences of Immigrant Parents and Their Children During the Second Trump Term
Issue BriefThis brief provides data from the 2025 KFF/New York Times Survey of Immigrants on the health and health care experiences of immigrant parents and their children in the U.S. amid the current policy environment.
-
Constrained Budgets Lead States to Restrict HIV Drug Access Through Ryan White
Policy WatchStates are facing constrained budgets, putting pressure on HIV programs, including the Ryan White HIV/AIDS Program. This Policy Watch explores how state Ryan White AIDS Drug Assistance Programs (ADAPs) are responding to these budget pressures, including by restricting eligibility and reducing the scope of services offered, actions that could led to negative health outcomes for people with HIV and lead to new HIV infections.
-
Overview of President Trump’s Executive Actions Impacting LGBTQ+ Health
Fact SheetThis tracker examines Executive Actions taken by the Trump administration that have the potential to impact LGBTQ+ people’s health. It lists the action taken by date, provisions relevant to LGBTQ+ health, and describes potential impact, including litigation challenging these actions.